Synthetica AD (SYN) Stock Overview
Through its subsidiaries, produces and sells hemodialysis and medical products in Bulgaria. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
SYN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Synthetica AD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | лв81.00 |
| 52 Week High | лв84.50 |
| 52 Week Low | лв66.00 |
| Beta | 0.065 |
| 1 Month Change | 0% |
| 3 Month Change | 1.25% |
| 1 Year Change | n/a |
| 3 Year Change | 62.00% |
| 5 Year Change | 82.43% |
| Change since IPO | 154.88% |
Recent News & Updates
Synthetica AD's (BUL:SYN) Weak Earnings May Only Reveal A Part Of The Whole Picture
Nov 06
Investors Appear Satisfied With Synthetica AD's (BUL:SYN) Prospects
Oct 28Recent updates
Synthetica AD's (BUL:SYN) Weak Earnings May Only Reveal A Part Of The Whole Picture
Nov 06Investors Appear Satisfied With Synthetica AD's (BUL:SYN) Prospects
Oct 28Synthetica AD (BUL:SYN) Will Be Hoping To Turn Its Returns On Capital Around
Jun 18Synthetica AD (BUL:SYN) May Have Issues Allocating Its Capital
Mar 24Introducing Synthetica AD (BUL:EHN), A Stock That Climbed 11% In The Last Five Years
Jan 27Is Synthetica AD's (BUL:EHN) 6.8% ROE Strong Compared To Its Industry?
Dec 17Shareholder Returns
| SYN | BG Medical Equipment | BG Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | 0.3% |
| 1Y | n/a | -2.7% | 14.0% |
Return vs Industry: Insufficient data to determine how SYN performed against the BG Medical Equipment industry.
Return vs Market: Insufficient data to determine how SYN performed against the BG Market.
Price Volatility
| SYN volatility | |
|---|---|
| SYN Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in BG Market | 7.1% |
| 10% least volatile stocks in BG Market | 2.0% |
Stable Share Price: SYN's share price has been volatile over the past 3 months compared to the BG market.
Volatility Over Time: Insufficient data to determine SYN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 107 | Iva Garvanska Sofiyanska | www.synthetica.bg |
Synthetica AD, through its subsidiaries, produces and sells hemodialysis and medical products in Bulgaria. It also engages in real estate management activities; and provides solar energy, as well as heating, ventilation, air conditioning, lighting, and industrial systems. The company is based in Sofia, Bulgaria.
Synthetica AD Fundamentals Summary
| SYN fundamental statistics | |
|---|---|
| Market cap | лв243.00m |
| Earnings (TTM) | лв2.35m |
| Revenue (TTM) | лв24.60m |
Is SYN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SYN income statement (TTM) | |
|---|---|
| Revenue | лв24.60m |
| Cost of Revenue | лв19.33m |
| Gross Profit | лв5.28m |
| Other Expenses | лв2.93m |
| Earnings | лв2.35m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.78 |
| Gross Margin | 21.45% |
| Net Profit Margin | 9.56% |
| Debt/Equity Ratio | 354.9% |
How did SYN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/09 23:10 |
| End of Day Share Price | 2025/11/26 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Synthetica AD is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.